Discover millions of ebooks, audiobooks, and so much more with a free trial

Only $11.99/month after trial. Cancel anytime.

Women and Health
Women and Health
Women and Health
Ebook5,413 pages76 hours

Women and Health

Rating: 0 out of 5 stars

()

Read preview

About this ebook

Women and Health is a comprehensive reference that addresses health issues affecting women of all ages — from adolescence through maturity. It goes far beyond other books on this topic, which concentrate only on reproductive health, and has a truly international perspective. It covers key issues ranging from osteoporosis to breast cancer and other cancers, domestic violence, sexually transmitted diseases, occupational hazards, eating disorders, heart disease and other chronic illnesses, substance abuse, and societal and behavioral influences on health.

In this second edition of Women and Health, chapters thoughtfully explore the current state of women’s health and health care, including the influences of sex and gender on the occurrence of a wide variety of diseases and conditions. All chapters have been extensively updated and emphasize the epidemiology of the condition — the etiology, occurrence, primary and secondary prevention (screening), risk factors, surveillance, changing trends over time, and critical analysis of the diagnostic and treatment options and controversies. Treatment sections in each chapter have been expanded to create a stronger dialogue between epidemiologists and women's health practitioners.

  • Saves researchers and clinicians time in quickly accessing the very latest details on a broad range of women’s health issues, as opposed to searching through thousands of journal articles
  • Provides a common language for epidemiologists, public health practitioners, and women’s health specialists to discuss the behavioral, cultural, and biological determinants of women’s health
  • Researchers and medical specialists will learn how the gender-specific risks and features of one organ system’s diseases affect the health of other organ systems
    • For example: Hormone replacement therapy used to treat imbalance within the endocrine system is also being used to prevent and treat cardiovascular disease; Drugs developed for type 2 diabetes are now being used in chemoprevention
  • Orients the non-gerontologist about the importance of considering the entire life cycle of women within research designs and treatment plans
  • Professors teaching courses in women’s health will use slides and additional materials to structure lectures/courses; students will use slides as a unique resource to study for exams
LanguageEnglish
Release dateDec 31, 2012
ISBN9780123849793
Women and Health

Related to Women and Health

Related ebooks

Social Science For You

View More

Related articles

Reviews for Women and Health

Rating: 0 out of 5 stars
0 ratings

0 ratings0 reviews

What did you think?

Tap to rate

Review must be at least 10 words

    Book preview

    Women and Health - Marlene B. Goldman

    Table of Contents

    Cover image

    Title page

    Front-matter

    Copyright

    Dedication

    Preface to the Second Edition

    Preface to the First Edition

    List of Contributors

    Introduction

    20th Century Achievements

    21st Century Challenges

    In Closing

    Part I: Women, Health, and Medicine

    Section 1: Introduction to Women’s Health

    Chapter 1. Women’s Health in the 21st Century

    Why Women’s Health?

    The Second Edition

    An Overview of the Health of Women

    Future Directions in the Study of Women’s Health

    References

    Chapter 2. The Mutability of Women’s Health with Age: The Sometimes Rapid, and Often Enduring, Health Consequences of Injustice

    Sex, Gender and Survival

    Age, Health and Weathering

    Stress Physiology and Aging

    Global Application of Weathering

    References

    Chapter 3. Current Approaches to Women’s Health Care

    Women’s Health through a Health Services Lens

    Changes in the Paradigm of Women’s Health

    Women’s Interactions with the Health Care System

    New Models for Women’s Health Services and Research

    Future Considerations and Challenges

    Women Become Active Stakeholders in their Care

    Acknowledgment

    References

    Chapter 4. The Impact of Health Coverage on Women’s Access to Care in the US

    Introduction

    Health Coverage for Women Today

    Insurance Regulations Affecting Services of Importance to Women

    How Coverage Affects Use of Health Care Services

    Costs and Other Barriers to Care

    Coverage Concerns for Older Women

    Health Reform and Women’s Coverage

    Conclusion

    References

    Chapter 5. Complementary, Alternative, and Integrative Medicine and Women’s Health

    Introduction/Background

    CAM Modalities in Women

    Clinical Conditions Difficult to Manage Solely with Conventional Medicine

    Epidemiologic Issues, Including Research Methodology and Public Health Impact

    Summary and Conclusions/Future Directions

    References

    Chapter 6. Research on the Health of Sexual Minority Women

    Importance of Studying the Health of Sexual Minority Women

    Who are Sexual Minority Women?

    History of Research on the Health of Sexual Minority Women

    Specific Health Concerns for Sexual Minority Women

    Barriers and Facilitators to Health Care Access

    Future of Research on Sexual Minority Health

    References

    Section 2: Research Methods in Women’s Health

    Chapter 7. Understanding Research Designs

    Introduction

    Terminology

    The Randomized Trial Design

    The Cohort Design

    The Case-Control Design

    The Cross-Sectional Design

    Case Reports and Case Series

    The Ecological Design

    Sources of Error in Epidemiologic Studies

    Conclusion

    References

    Chapter 8. Progress in Women’s Health Research

    Introduction

    Gender Disparity in Health Research

    Intervention Studies

    Observational Studies

    Remedying the Disparity: Advocacy, Seminal Studies, NIH Response

    Women’s Health Movement

    Seminal Studies Restricted to Women

    Office of Research on Women’s Health

    Inclusion of Women in Clinical Trials

    Increase in Number of Women Researchers

    Lessons Learned and Future Challenges

    Research Agenda

    Conclusions

    References

    Chapter 9. Life Course Approach to Research in Women’s Health

    Introduction

    Life Course Epidemiology

    Life Course Theory and Models

    Life Course Influences on Health

    Life Course Reproductive Characteristics and Health

    Life Course Methodology and Study Design

    Prevention and Policy

    References

    Chapter 10. Principles of Genetics and Genomics

    Introduction

    Understanding the Human Genome

    The Genetic Contribution to Disease

    Other ‘Omics’ Initiatives

    Clinical and Public Health Implications

    Acknowledgments

    References

    Part II: Sexual and Reproductive Health

    Section 3: Introduction: Sexual and Reproductive Health

    Section 3. Introduction: Sexual and Reproductive Health

    Chapter 11. Puberty and Adolescent Pregnancy

    Hormonal Regulation of Growth at Adolescence

    Biological Maturation and Maturity Indicators

    Adolescent Changes in Linear Growth and Body Composition

    Characteristics Influencing Adolescent Growth and Maturation

    Factors Influencing Secular Change in Growth and Maturation

    Short Term Consequences of Early Maturation

    Long Term Consequences of Early Maturation

    References

    Chapter 12. Menstruation and Menstrual Disorders: The Epidemiology of Menstruation and Menstrual Dysfunction

    Introduction

    Normal Variation in Menstrual Cycles Across the Lifespan

    Menstrual Disorders

    Regional, Ethnic, and Socioeconomic Differences in Menstrual Cycle Characteristics

    Risk Factors Related to Menstrual Cycle Characteristics

    Epidemiologic Issues in the Study of Menstrual Function

    Summary, Conclusions, and Future Directions

    References

    Chapter 13. Premenstrual Syndrome

    Definition and Diagnosis

    Incidence, Prevalence, and Burden of PMS

    Pathophysiology

    Risk Factors

    Treatments

    Conclusions

    References

    Chapter 14. Women’s Fecundability and Factors Affecting It

    Introduction

    Background and Terminology

    Estimates of Fecundability

    Factors Affecting Fecundability

    Methodological Issues

    Future Directions

    Acknowledgments

    References

    Chapter 15. Contraception

    Contraceptive Use in the United States

    Contraceptive Cost

    Contraceptive Use: Medical Eligibility Guidelines

    Contraceptive Methods

    References

    Chapter 16. Induced Abortion

    Introduction: History, Background, Definitions, Chapter Objectives

    Abortion Procedures

    Ascertainment of Induced Abortion

    Induced Abortion in the US

    Complications of Abortion – Mortality and Morbidity

    Global Abortion

    Public Health Impact of Induced Abortion – US and Worldwide

    Summary and Conclusions

    References

    Chapter 17. Infertility

    Definition of Infertility

    Historical Evolution and Trends

    Prevalence of Infertility

    Access to and Use of Medical Services

    Clinical Presentation

    Risk Factors

    Clinical Issues

    Epidemiological Methods

    Conclusions and Future Directions

    References

    Chapter 18. Endometriosis

    Description of Endometriosis and Its Impact

    Disease Ascertainment and Methods Issues

    Frequency of Endometriosis Occurrence

    Theories of Endometriosis Pathogenesis

    Risk Factors for Endometriosis

    Genetic Markers of Susceptibility

    Endometriosis Treatment

    Summary, Conclusions, and Future Directions

    References

    Chapter 19. Uterine Leiomyomata

    Introduction

    Anatomic, Histopathological, and Molecular Characteristics

    Issues in the Design of Epidemiological Studies

    Frequency of Occurrence and Demographic Patterns

    Etiological Hypotheses and Risk Factors

    Clinical Epidemiology

    Summary and Directions for Future Research

    Acknowledgment

    References

    Chapter 20. Assisted Reproductive Technologies

    Introduction

    The Epidemiology of Infertility

    Assisted Reproductive Technologies (ART)

    General Steps Involved with Assisted Reproductive Technologies

    Indications for Assisted Reproductive Technologies

    Patient Selection for ART

    Defining Success in ART

    Predicting Success with ART: Is it Possible?

    Complications of ART

    Conclusions and Future Directions

    References

    Chapter 21. Pregnancy Complications and Future Maternal Health

    Introduction

    Cardiometabolic Changes in Pregnancy

    Gestational Diabetes Mellitus

    Pre-eclampsia

    Opportunities for Intervention and Prevention

    Conclusion

    References

    Chapter 22. Labor and Delivery

    Introduction

    Topics in Labor and Delivery

    Effecting Change in Clinical Practice and in the Organization of Health Services

    Conclusion

    References

    Chapter 23. Female Sexuality and Sexual Function

    Introduction

    Sexuality Throughout the Life Course

    The Interactive Biopsychosocial Model of Sexuality and Health

    Normal Sexual Function and Response

    Female Sexual Dysfunction

    Cancer and Sexuality

    Instruments to Measure Sexual Function

    Conclusion

    References

    Chapter 24. Vulvodynia

    Introduction

    Definition

    Historical Evolution

    Distribution in Women

    Etiology

    Clinical Issues

    Public Health Importance and Future Directions

    References

    Chapter 25. Menopause: Its Epidemiology

    Introduction

    Definition of the Menopause

    Hormonal Events and the Menopausal Transition

    Age and Duration of the Menopausal Transition

    ‘Symptomatology’ of the Menopause

    Is the Menopausal Transition a Keystone in Subsequent Chronic Disease?

    Theories and Conceptual Models of Menopause

    Summary

    References

    Chapter 26. Overview of Pelvic Floor Disorders: Epidemiology, Diagnosis, and Treatment

    Introduction

    Pelvic Organ Prolapse

    Bladder Dysfunction

    Bowel Dysfunction

    Sexual Dysfunction

    Methodology for Study

    Summary and Conclusions

    References

    Chapter 27. Hysterectomy

    Introduction

    Definition and History

    Epidemiology

    Factors Associated with Hysterectomy

    Indications for Hysterectomy

    Types and Surgical Routes of Hysterectomy

    Prophylactic Bilateral Oophorectomy

    Patient-Centered Outcomes

    Length of Stay

    Cost of Hysterectomy

    Alternatives to Hysterectomy

    Implications for Practice

    Implications for Research

    References

    Section 4: Introduction: Sexually Transmitted Infections

    Section 4. Introduction: Sexually Transmitted Infections

    Gender Differences in Risk for Sexually Transmitted Diseases

    Section Overview

    New Directions

    Chapter 28. Gonococcal Infection in Women

    Introduction

    Microbiology

    Epidemiology of Gonococcal Infections in Women

    Clinical Spectrum of Infection in Women

    Diagnosis of Gonococcal Infections

    Specimen Collection

    Treatment of Women with Gonococcal Infections

    Patient Follow-Up after Therapy

    Public Health Aspects of Gonococcal Infections

    References

    Chapter 29. Chlamydia trachomatis

    Introduction

    Epidemiology

    Transmission

    Natural History of Infection

    Screening Strategies

    Clinical Syndromes

    Complications

    Sequelae

    Risk of HIV Transmission

    Microbiology and Diagnosis

    Management

    STD Control

    Cost Effectiveness

    Conclusions

    References

    Chapter 30. Syphilis in Women

    Introduction and History

    Epidemiology of Syphilis

    Considerations in Transmission of Syphilis

    Natural History and Clinical Manifestations of Syphilis

    Diagnostic Methods

    Treatment

    Effects of HIV on Syphilis

    Syphilis and Pregnancy

    Summary

    References

    Chapter 31. Vaginal Infections

    Introduction

    The Normal Vaginal Ecosystem

    Diagnostic Work-Up of Vaginitis

    Vulvovaginal Candidiasis

    Trichomoniasis

    Bacterial Vaginosis

    Conclusion

    References

    Chapter 32. Genital Herpes

    Introduction

    Epidemiology

    Clinical Epidemiology

    Neonatal Herpes

    Diagnosis

    Therapy

    Prevention

    Resources for Persons with Genital Herpes

    References

    Chapter 33. HIV and AIDS in Women

    Introduction

    Defining and Detecting HIV/AIDS

    HIV Acquisition and Transmission

    Distribution of HIV/AIDS in Women

    Natural History and Clinical Management

    Factors Associated with HIV Transmission

    Prevention

    Conclusions

    References

    Chapter 34. Human Papilloma Virus Infection in Women

    Introduction

    Virology

    Pathogenesis and Mechanisms of Oncogenicity

    Clinical Classification of Oncogenic Changes in the Cervical Epithelium

    Epidemiology of HPV

    Transmission of Infection

    Risk Factors for HPV Infection and Disease

    Clinical Screening and Diagnosis of HPV-Related Disease

    Treatment of HPV-Related Disease

    Primary Prevention: HPV Vaccines

    Conclusions

    References

    Chapter 35. Pelvic Inflammatory Disease and Chronic Pelvic Pain

    Introduction

    Background

    Definition of Chronic Pelvic Pain

    Issues Related to Ascertainment

    Historical Evolution/Trends

    Distribution in Women, Including Incidence, Prevalence, and Mortality Statistics

    Risk Factors

    Biological Markers of Susceptibility or Exposure

    Genetic Markers

    Clinical Issues

    Methodological Issues for Epidemiological Studies

    Prevention and Self-Care

    Global Issues

    Summary and Conclusions/Future Directions

    References

    Chapter 36. Urinary Tract Infection

    Overview

    Range of Clinical Entities and Associated Morbidity

    UTI Distribution among Otherwise Healthy Women

    UTI Reservoir

    UTI Transmission

    Risk Factors

    Bacterial Virulence Factors

    Clinical Issues: UTI among Otherwise Healthy Women

    Epidemiological Issues

    Future Directions

    References

    Part III: Occupational, Environmental, and Social Determinants of Health

    Section 5: Occupational and Environmental Determinants of Health

    Section 5. Occupational and Environmental Determinants of Health

    Introduction

    Chapter 37. Working Women in the United States: A Statistical Profile

    Introduction

    Wages, Hours, and Family Responsibilities

    Occupational Injuries and Illnesses

    Concluding Remarks

    References

    Chapter 38. International Perspectives: Women’s Occupational Health

    The ‘Developed/Developing’ Split

    Traditional Unpaid Employment

    The Informal Sector

    Implications for Occupational Health and Safety

    An Additional Hazard: Violence

    Economic and Social Responses to Women in the Workforce

    Documenting the Issues

    References

    Chapter 39. Multiple Roles and Complex Exposures

    Exposures to ‘Invisible’ Workplace Health Determinants

    Prolonged Standing

    Stress

    Workplace Contributions to Work–Family Balancing

    Equality and Health

    Analytical Approaches

    Acknowledgments

    References

    Chapter 40. Reproductive Hazards of Occupational and Environmental Exposures

    Introduction

    Chemical Agents

    Physical Agents

    Biological Agents

    Physical and Psychosocial Strain

    Methodological Issues

    Risk Assessment, Risk Communication, and Prevention

    Concluding Remarks

    References

    Chapter 41. Work-Related Musculo-Skeletal Disorders

    Definitions

    Gender and Musculo-skeletal Disorders

    At-Risk Occupations

    Interpreting Gender Differences

    Conclusion and Research Needs

    References

    Chapter 42. Occupational Cancer

    Introduction

    Carcinogens in the Workplace

    Selected Cancer Sites

    Epidemiologic Issues/Future Directions

    Conclusion

    References

    Chapter 43. Environmental Exposures and Cancer

    Introduction

    Definition of the Topic: Environmental Exposures and Cancer

    Epidemiological Evidence

    Historical Evolution/Trends

    Distribution of Environmental Cancer in Women, Including Incidence, Prevalence, and Mortality Statistics

    Host Determinants

    Influence of Women’s Social Roles or Context on Environmental Cancer

    Risk Factors

    Biological Markers of Susceptibility or Exposure

    Clinical Issues

    Epidemiological Issues

    Is Breast Cancer an Environmental Cancer?

    Conclusions

    Acknowledgments

    References

    Section 6: Introduction: An Introduction to the Social Determinants of Women’s Health

    Section 6. Introduction: An Introduction to the Social Determinants of Women’s Health

    Chapter 44. Socioeconomic Determinants of Women’s Health: The Changing Landscape of Education, Work, and Marriage

    Introduction

    Education Effects on Health

    Effects of Work on Women’s Health

    Marriage and Women’s Health

    Recent Trends in Women’s Education, Work, and Marital Status

    Understanding Recent Trends in Mortality and Morbidity in the Context of Changes in Social Determinants of Health

    How Will Recent Trends in Education, Marriage History, and Labor Force Participation Affect the Future of Women’s Health?

    Challenges and Future Directions

    Conclusion

    References

    Chapter 45. Women, Stress, and Health

    The Social Stress Model

    Key Sources of Stress in Women’s Lives

    Women and Aging

    Positive Features of the Social Environment

    Intersections with Race and Sexuality

    Mechanisms

    Directions for Research

    References

    Chapter 46. Tobacco Use: Trends, Determinants, and Health Effects

    Introduction

    Trends in Tobacco Use among Women and Girls

    Determinants of Tobacco Use among Women and Girls

    Health Effects of Tobacco Use among Women

    Health Effects of Second-hand Smoke

    Conclusions

    References

    Chapter 47. Alcohol Is a Women’s Health Issue

    Introduction

    Methodological Issues in Studying Patterns of Alcohol Consumption

    Alcohol-attributable Deaths and Disability-adjusted Life Years among Women Globally

    History of Alcohol as a Women’s Health Issue

    Conclusions

    References

    Chapter 48. Intimate Partner Violence

    Introduction

    Prevalence

    Risk Factors

    Challenges

    Conclusion

    Acknowledgment

    References

    Chapter 49. Do Social Policies Influence the Health of Women and their Children?: Implications for Designing Future Policies Using a ‘Social Determinants of Health’ Lens

    Introduction: Social Policies, Social Determinants of Health, Gender, and Health Outcomes

    Literature Review Methods

    Results: Policy Overviews and Health Impacts

    Conclusions and Implications: Lessons to Apply to Future Design of Social Policies to Improve the Health of Women

    Conclusion

    References

    Chapter 50. The Impact of the Built Environment on Health

    Introduction

    Definition of the Topic: the Neighborhood Built Environment and Health

    Methods in Built Environment Research

    The Modern Built Environment: Sprawl and Transportation

    Air Pollution

    Overweight/Obesity, Physical Activity, and Diet

    Motor Vehicle Crashes and Motor Vehicle-Pedestrian Collisions

    Mental Health and Social Capital

    Disparities

    Research Needs to Understand the Impact of the Built Environment on Health

    Conclusion

    References

    Part IV: Chronic Disease

    Section 7: Introduction: Autoimmune Diseases

    Section 7. Introduction: Autoimmune Diseases

    How Does Autoimmunity Occur?

    Why Do Autoimmune Diseases Occur?

    Why Do Autoimmune Diseases Preferentially Develop in Women?

    What is the Relationship Between Sex Hormones and Autoimmune Diseases?

    Summary

    Chapter 51. Rheumatoid Arthritis

    Introduction

    Etiology and Pathogenesis

    Epidemiology

    Classification Criteria

    Evaluation and Management of RA

    Prognosis and Outcomes in RA

    Future Directions in Rheumatoid Arthritis

    References

    Chapter 52. Multiple Sclerosis

    Overview of Multiple Sclerosis

    Pathophysiology

    Diagnostic Evaluation

    Clinical Parameters

    Reproductive Life: MS, Fertility, and Pregnancy

    Disease Monitoring

    Treatment Strategies

    Summary

    References

    Chapter 53. Systemic Lupus Erythematosus

    Introduction

    SLE Epidemiology

    Clinical Presentation and Management

    Management of SLE

    Summary

    References

    Chapter 54. Sjögren’s Syndrome

    Introduction and Background

    Primary and Secondary Sjögren’s Syndrome

    Evolution Since 1930

    Definition of Sjögren’s Syndrome

    Epidemiology

    Host and Environmental Factors

    Clinical Manifestations

    Laboratory Abnormalities

    Management of Sjögren’s Syndrome

    Summary

    Note in Proof

    References

    Chapter 55. Asthma

    Introduction

    Asthma Diagnosis and Management

    Increasing Prevalence of Asthma

    Gender Differences

    Risk Factors

    Discussion

    Acknowledgments

    References

    Section 8: Endocrinology and Women’s Health

    Section 8. Endocrinology and Women’s Health

    Introduction

    Chapter 56. The Obesity Epidemic and Women’s Health

    Introduction

    Definitions and Classifications

    Historical Perspective (Evolution/Trends)

    The Current Obesity Epidemic

    Why do Men and Women in the United States Gain Weight?

    Why Do Women Regain Weight?

    Host Susceptibility–Genetics. Is Obesity Inherited?

    Obesity-Associated Morbidity and Mortality

    Heterogeneity in Obesity-Related Risk of Disease: Why Do Some Obese Women Have More Disease Than Other Women?

    Epidemiological Issues–Older Women

    Clinical Issues: Diagnosis and Treatment

    Summary

    References

    Chapter 57. Diabetes in Women

    Introduction

    Definition

    Prevalence, Public Health Burden, and Distribution of Diabetes

    Risk Factors for Diabetes

    Health Consequences of Diabetes

    Unique Issues to Women

    Treatment and Prevention of Diabetes

    Conclusions

    References

    Chapter 58. Thyroid Disease and Women

    Introduction

    Thyroid Physiology

    Biochemical Thyroid Tests

    Overview of Thyroid Disease

    Summary and Perspective

    References

    Chapter 59. Management of Menopausal Symptoms in the Post-Women’s Health Initiative Era

    Introduction/Historical Perspective

    Definition of the Menopause

    Symptoms of the Menopause Transition and Postmenopausal Phases

    Summary

    References

    Chapter 60. Vitamin D and Disease Prevention in Women

    Introduction

    National Guidelines for Vitamin D Intake

    Low Vitamin D: Prevalence and Risk Factors

    Methodological Considerations

    Outcomes

    Clinical Recommendations

    Conclusion and Future Research Directions

    References

    Chapter 61. Osteoporosis

    Introduction

    Definition and Pathophysiology

    Public Health Impact

    Rates and Patterns of Bone Loss

    The Rates of Fracture

    Secular Changes in Hip and Other Fractures

    Prevalence of Osteoporosis by BMD

    Risk Factors for Fracture

    Novel Risk Factors for Fracture in the Last Decade

    Summary and Future Directions

    References

    Section 9: Cardiovascular Disease in Women

    Section 9. Cardiovascular Disease in Women

    Introduction

    Unique Risk Factors in Women

    Prevention

    Disparities among Women

    Changes in our Understanding of CVD in Women

    CVD Chapters

    Future Directions

    Chapter 62. Overview of Risk Factors for Cardiovascular Disease

    Introduction

    Demographic Characteristics

    Family History of Cardiovascular Disease

    Cigarette Smoking

    Hypertension

    Lipids and Lipoproteins

    Physical Activity

    Diabetes Mellitus

    Body Size and Distribution

    Nutrition

    Novel Biomarkers

    Summary and Conclusions

    References

    Chapter 63. Lipids in Women

    Introduction

    Lipid and Lipoprotein Metabolism

    Role of Lipids in Atherosclerosis and Cardiovascular Prevention

    Trends in Lipid Levels

    Unique Issues Affecting Lipids in Women

    Measurement, Screening, Diagnosis and Treatment of Lipid Disorders

    Future Research

    Conclusions

    References

    Chapter 64. Diagnosis and Treatment of Ischemic Heart Disease in Women

    Introduction

    Prevalence and Mortality from Coronary Heart Disease

    Risk Factors

    Clinical Presenting Symptoms in Women

    Diagnosis

    Management

    Conclusion

    References

    Chapter 65. Emotions and Cardiovascular Disease

    Introduction

    The Role of Emotions in Incident CVD

    Studies of Patients with Established CVD

    Future Directions

    Conclusion

    Acknowledgments

    References

    Chapter 66. Cerebrovascular Disease in Women

    Introduction

    Epidemiology of Stroke

    Genetics of Stroke

    Clinical Considerations

    Risk Factor Reduction and Public Health Impact

    Conclusion

    References

    Chapter 67. Venous Thromboembolism

    Introduction

    Deep Vein Thrombosis

    Pulmonary Embolism

    Established and Potential Risk Factors for Venous Thromboembolism

    Pregnancy-Associated VTE

    Postmenopausal Hormone Therapy Use

    Contraceptive Usage

    Long-Distance Air Travel

    Cardiovascular Disease Risk Factors

    Recurrence and Other Consequences of VTE

    Epidemiological Issues, Public Health Considerations, and Conclusions

    References

    Chapter 68. Arrhythmias in Women: Atrial Fibrillation and Sudden Cardiac Death

    Introduction

    Part 1: Atrial Fibrillation

    Part 2: Sudden Cardiac Death

    References

    Chapter 69. Heart Failure in Women: Epidemiology, Prognosis, and Management

    Introduction/Background

    Definition of Heart Failure

    Cardiomyopathy

    Issues Related to Ascertainment

    Incidence, Prevalence, and Mortality Statistics

    Risk Factors

    Biological Markers of Susceptibility or Exposure

    Genetic Markers of Susceptibility or Exposure

    Clinical Issues (Diagnosis, Treatment)

    Summary and Conclusions/Future Directions

    References

    Chapter 70. Hypertension in Women

    Introduction/Background

    Definition of the Topic

    Issues Related to Ascertainment

    Historical Evolution/Trends

    Hypertension in Young Women

    Hypertensive Disorders of Pregnancy

    Postmenopausal Hypertension

    Blood Pressure Control

    Risk Factors for Hypertension in Women

    Treatment of Hypertension in Women

    Lifestyle Intervention in Hypertension Treatment

    Pharmacological Treatment of Primary Hypertension in Women

    Summary

    Acknowledgments

    References

    Section 10: Cancer

    Section 10. Cancer

    Introduction

    Perspectives on Cancer

    Signs of Progress

    Persistent Challenges

    Prospects

    Chapter 71. Cancer in Women: Global Burden and Insights from Gender Comparisons

    Introduction

    Data Sources and Methods

    Global Patterns of Cancer among Women

    Disparities between the Sexes in Cancers Common to Both Sexes

    The Future Burden of Cancer in Women

    Appendix A Human Development Index Countries (2007 Indices)

    References

    Chapter 72. Breast Cancer Epidemiology

    Introduction

    Endogenous Hormones that Biologically Mediate Breast Carcinogenesis

    Melatonin

    Risk Factors

    Conclusion

    References

    Chapter 73. Genetic Epidemiology of Breast Cancer

    Evidence for a Genetic Component of Breast Cancer

    Autosomal Dominant Predisposition to Cancer

    Single Gene Predispositions of Moderate Penetrance

    Low Penetrance, Common Alleles

    Clinical Implications of Genetic Variants

    Reflections and Future Directions

    Summary

    References

    Chapter 74. Breast Cancer Screening

    Introduction

    History of Screening Trials

    Efficacy of Breast Screening

    Discussion

    References

    Chapter 75. Ovarian Cancer

    Biology of Ovarian Cancer

    Ovarian Cancer in Populations

    Genetic Susceptibility to Ovarian Cancer

    Reproductive Factors

    Endogenous Hormones and Ovarian Cancer Risk

    Exogenous Hormone Use and Ovarian Cancer Risk

    Factors Related to Inflammation

    Body Size

    Smoking, Alcohol, Diet

    Ovarian Cancer Screening

    Summary and Future Research Directions

    References

    Chapter 76. Endometrial Cancer

    Pathology and Diagnosis

    Patterns of Disease

    Environmental and Behavioral Determinants

    Clinical Issues

    Epidemiological Issues

    Prevention and Self-Care

    Conclusions

    References

    Chapter 77. Cervical Cancer: Burden of Disease and Risk Factors

    Introduction

    Cervical Cancer Histopathology

    Incidence and Mortality of Cervical Cancer: Worldwide Perspective

    Time Trends in Cervical Cancer

    Natural History of Human Papillomavirus Infection and Cervical Cancer

    Risk Factors for Cervical Cancer

    The Spectrum of HPV Related Diseases

    Future Directions in Research and Public Health

    Acknowledgments

    References

    Chapter 78. Vaccination and Screening in Cervical Cancer Control and Prevention

    Introduction

    Natural History of Cervical Cancer and the Basis for Prevention

    Cytology Screening as Prevention Paradigm

    Secondary Prevention via Modern Screening Technologies

    Primary Prevention via HPV Vaccination

    Integration of Primary and Secondary Prevention Strategies

    Conclusion

    Acknowledgments

    References

    Chapter 79. Epidemiology of Lung Cancer in Women

    Introduction

    Magnitude of the Problem and Descriptive Epidemiology

    Risk Factors

    Acknowledgment

    References

    Chapter 80. Colorectal Cancer in Women

    Introduction

    Descriptive Epidemiology of Colorectal Cancer

    Analytic Epidemiology of CRC and Polyps

    Clinical Characteristics of CRC

    Next Research Steps Including Methodological Issues

    Summary

    References

    Chapter 81. The Epidemiology of Melanoma of the Skin

    Introduction

    Trends

    Incidence, Prevalence and Mortality

    Host and Environmental Determinants

    Prevention and Self-Care

    Screening

    Diagnosis and Treatment

    Global Environment

    References

    Chapter 82. Cancer Prevention for Women

    Introduction

    Cancer Prevention: The State of the Science

    Unique Issues for Women in Cancer Prevention

    Changing Cancer Risk Behaviors: From Individuals to Policy

    Future Directions

    References

    Section 11: Mental Disorders – Introduction

    Section 11. Mental Disorders – Introduction

    Introduction

    Chapter 83. Gender and Mood Disorders

    Introduction and Background

    Mood Disorders Defined

    Issues Related to Ascertainment

    Historical Trends

    Distributions

    Influences of Women’s Social Roles

    Risk Factors

    Biological Markers of Susceptibility and Exposure

    Clinical Issues

    Epidemiological Issues

    Conclusions and Future Directions

    References

    Chapter 84. Anxiety Disorders in Women

    Introduction

    Sex Differences in the Prevalence of Anxiety Disorders

    Comorbidity

    Familial and Genetic Risk Factors

    Temperamental and Biological Factors

    Psychosocial Risk Factors and Impact

    Treatment of Anxiety

    Summary and Future Directions

    Acknowledgments

    Appendix A

    Agoraphobia

    Generalized Anxiety Disorder

    Specific Phobia

    Social Phobia

    References

    Chapter 85. Posttraumatic Stress Disorder

    Introduction

    Defining Trauma and PTSD

    Etiological Factors in Women

    Phenomenology of PTSD in Women

    Assessment

    Methodological Issues

    Treatment of PTSD in Women

    Conclusions

    References

    Chapter 86. Psychosis in Women: Gender Differences in Presentation, Onset, Course and Outcome of Schizophrenia

    Introduction

    Understanding Psychotic Disorders

    Development of Schizophrenia in Women

    Management of Schizophrenia in Women

    Treatment for Women with Schizophrenia

    Psychological Treatment for Women with Schizophrenia

    Conclusions

    Acknowledgments

    References

    Chapter 87. Eating Disorders

    Introduction

    Definition and Diagnosis

    Classification

    Epidemiology

    Risk Factors

    Intervention and Treatment

    Summary and Conclusions

    References

    Chapter 88. Addictive Disorders

    Introduction

    Dependence on Psychoactive Substances

    Pathological Gambling

    Kleptomania

    Trichotillomania

    Compulsive Buying

    Pathological Love

    Conclusions

    References

    Section 12: Poorly Understood Conditions

    Section 12. Poorly Understood Conditions

    Introduction

    Issues with Case Definition and Ascertainment

    The Multidimensional Nature of Poorly Understood Conditions

    Risk Factors and Consequences and Their Implications for Treatment

    Future Directions

    Chapter 89. Chronic Fatigue Syndrome

    Introduction

    Epidemiology

    Symptoms, Signs and Laboratory Findings

    Prognosis

    Pathophysiology of CFS

    Treatment of CFS

    References

    Chapter 90. Fibromyalgia: A Central Sensitivity Syndrome

    Introduction

    Epidemiology and Prevalence

    Nomenclature

    What is Central Sensitization?

    Pathophysiological Mechanism of Central Sensitization

    Can Central Sensitization be Produced or Maintained without Peripheral Nociception?

    Association of CS/FMS in Chronic Diseases with Structural Pathology (CDSP)

    Factors that may Trigger or Contribute to Central Sensitization

    Evidence of Central Sensitization in FMS

    Clinical Manifestations of FMS

    Diagnosis of FMS

    Management of FMS

    Conclusions

    References

    Chapter 91. Epidemiology of Headache in Women: Emphasis on Migraine

    Introduction

    Diagnostic Criteria

    Incidence

    Prevalence

    Female Hormones and Headache

    References

    Chapter 92. Irritable Bowel Syndrome

    Introduction

    Definition and Issues Related to Ascertainment

    Historical Evolution

    Distribution in Women

    Epidemiological Issues

    Health Care Seeking

    Risk Factors

    Clinical Issues

    Treatment

    Public Health Issues

    Conclusions

    References

    Chapter 93. Temporomandibular Disorders

    Background

    Definitions

    Issues Related to Ascertainment

    Historical Trends

    Distribution in Women

    Host and Environmental Determinants

    Influence of Women’s Social Roles

    Risk Factors

    Biological Markers of Susceptibility or Exposure

    Clinical Issues

    Epidemiological Issues

    Summary and Conclusions/Future Directions

    References

    Chapter 94. Multiple Chemical Sensitivity

    Introduction

    Epidemiology

    Risk Factors

    Diagnosing MCS

    Possible Mechanisms

    Skepticism Surrounding MCS

    Treatment

    Future Research in MCS

    Conclusions

    Acknowledgments

    References

    Part V: Geriatric Health

    Section 13: Aging

    Section 13. Aging

    Introduction

    Chapter 95. Morbidity, Disability, and Mortality

    Introduction

    Sociodemographic Characteristics

    Socioeconomic Status of Older Women

    Demography of Aging

    Functional Limitations and Disability

    Life Expectancy

    Active Life Expectancy

    Health Status

    Mortality

    Health Disparities

    Measurement Issues

    Summary

    References

    Chapter 96. Osteoarthritis and Other Musculoskeletal Diseases

    Introduction

    Definition and Classification

    Clinical Features of OA

    Descriptive Epidemiology of Osteoarthritis

    Risk Factors for the Development and Progression of Osteoarthritis

    Biomarkers and Osteoarthritis

    Management of Osteoarthritis

    References

    Chapter 97. Urinary and Fecal Incontinence in Older Women

    Introduction

    Definitions

    Epidemiology

    Global Issues

    Costs

    Etiology

    Clinical Issues

    Areas for Future Research

    Conclusion

    References

    Chapter 98. Hearing Loss and Aging

    Introduction

    Background

    Epidemiology of Hearing Loss

    Impact of Hearing Loss in Adults

    Clinical Issues in the Treatment of Hearing Loss

    Conclusion

    References

    Chapter 99. Visual Impairment

    Introduction

    Measurement of Visual Impairment

    Major Causes of Visual Impairment in the World

    Other Eye Conditions with Noted Gender Discrepancy

    Low Vision Rehabilitation

    Summary

    References

    Chapter 100. The Impact of Women’s Oral Health on Systemic Health

    Hormonal Changes and Oral Health

    Oral Diseases and Their Relationship to Women’s Health

    Systemic Diseases and Their Relationship to Women’s Oral Health

    Conclusion

    References

    Chapter 101. Cognitive Functioning in Aging Women

    Introduction

    Background

    Sex Differences in Incidence and Prevalence of Dementia

    Diversity and Disparity in Dementia

    Biological and Environmental Modulators of Cognitive Decline and Dementia

    Hormone Therapy

    Genetic Risk

    Summary

    References

    Chapter 102. The Role of Social Support in the Health and Well-Being of Older Adult Widows

    The Epidemiology of Widowhood

    Adapting to the Loss of a Spouse

    Dual Process Model of Coping

    The Notre Dame Widowhood Study (NDWS)

    Widowhood and Health

    Social Support and Health

    Conceptual and Methodological Importance for Future Research

    References

    Chapter 103. Long-Term Care: The Global Impact on Women

    Introduction

    The Aging Population

    What is Long-Term Care?

    Women in Need of Care

    Women as Informal Caregivers

    Caregiving Outcomes

    Institutional Long-Term Care

    Women as Caregivers in Institutional Long-Term Care Settings

    Environmental Determinants that Impact Quality of Care Received by Women in Long-Term Care Settings

    Creative Alternatives to Traditional Long-Term Care Settings

    Research and Public Health Impact on Long-Term Care

    Conclusion

    References

    Chapter 104. Caring for Women at the End of Life

    Introduction

    Epidemiology of Dying

    Role of Palliative Care and Hospice Care in Caring for patients at EOL

    Ethical Issues

    Communication and Medical Decision-Making

    Clinical Issues at the End of Life

    Implications for Health Care Policies at the End of Life

    Summary

    References

    Chapter 105. Successful Aging in Women

    Successful Aging in Women

    Definition

    Prevalence of Successful Aging

    Factors that Influence Successful Aging

    Behavioral Factors Influencing Successful Aging

    Additional Factors Associated with Successful Aging

    Measurement of Successful Aging

    Intervention to Facilitate Successful Aging Among Older Women

    Exercise Guidelines and How Much is Enough?

    Cognitive Stimulation

    Maintaining Purpose in Life

    Interventions to Strengthen Motivation

    Conclusion

    References

    Epilogue and Future Directions

    Index

    Front-Matter

    Copyright

    Academic Press is an imprint of Elsevier

    32 Jamestown Road, London NW1 7BY, UK

    225 Wyman Street, Waltham, MA 02451, USA

    525 B Street, Suite 1800, San Diego, CA 92101-4495, USA

    First edition 1999

    Second edition 2013

    Copyright © 2013 Elsevier Inc. All rights reserved

    Except chapters 3, 14, 16, 42, 84 and the Epilogue which are in the public domain

    No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means electronic, mechanical, photocopying, recording or otherwise without the prior written permission of the publisher Permissions may be sought directly from Elsevier’s Science & Technology Rights Department in Oxford, UK: phone (+44) (0) 1865 843830; fax (+44) (0) 1865 853333; email: permissions@elsevier.com. Alternatively, visit the Science and Technology Books website at www.elsevierdirect.com/rights for further information.

    Notice

    No responsibility is assumed by the publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made.

    Medicine is an ever-changing field. Standard safety precautions must be followed, but as new research and clinical experience broaden our knowledge, changes in treatment and drug therapy may become necessary or appropriate. Readers are advised to check the most current product information provided by the manufacturer of each drug to be administered to verify the recommended dose, the method and duration of administrations, and contraindications. It is the responsibility of the treating physician, relying on experience and knowledge of the patient, to determine dosages and the best treatment for each individual patient. Neither the publisher nor the authors assume any liability for any injury and/or damage to persons or property arising from this publication.

    British Library Cataloguing-in-Publication Data

    A catalogue record for this book is available from the British Library

    Library of Congress Cataloging-in-Publication Data

    A catalog record for this book is available from the Library of Congress

    ISBN: 978-0-12-384978-6

    For information on all Academic Press publications visit our website at store.elsevier.com

    Typeset by MPS Limited, Chennai, India www.adi-mps.com

    Printed and bound in China

    12 13 14 15 16 10 9 8 7 6 5 4 3 2 1

    Dedication

    I dedicate this book to my co-editors, Drs. Rebecca Troisi and Kathy Rexrode, whose efforts made this edition of the book possible. (MBG)

    I dedicate this book to the women and men who have nurtured and challenged me, Miriam, Cathy and Marcie Troisi, Chloe Troisi-Rogers, Ethan Rogers and Nicholas Troisi, as well as to my co-editors Marlene and Kathy, who made this project intellectually fulfilling, and more importantly, a great pleasure. (RT)

    I dedicate this book to my patients and colleagues who continually inspire me, to Bill, Nancy and Betty Rexrode, and Steven, Lev and Theo Goldman for their constant encouragement and support, as well as to my co-editors for their vision of and commitment to women’s health. (KMR)

    Preface to the Second Edition

    In the decade since the publication of the first edition of Women and Health new issues regarding the health of women have emerged. We have begun to more fully recognize that the diversity among women is as broad as the differences between women and men. There have been changes in lifestyle, occupation, and other potential sources of environmental exposures. Medical technologies for disease screening, diagnosis, and treatment have evolved. Research has begun to incorporate new analytic techniques, including the opportunities presented by genetics and related fields. For some time we have known that diseases affect the sexes differently and that understanding the etiology, occurrence, diagnosis, and treatment, as well as the social and cultural context for each sex is critical. Today’s scientists and clinicians are more likely to think in terms of gender-based medicine than women’s or men’s health, per se.

    As with the first edition, the content of this book is designed to address the behavioral and societal, as well as the biological determinants of the health and well-being of women, young and old, throughout their lives. Our intent is to provide a resource of what we understand about the health issues facing women and to inform the work of the professionals who conduct research and provide care for women, and in so doing, improve the quality of women’s lives. We are committed to producing a book that is intended not only for the medical and scientific community, but also for consumers of health care. It is our conviction that the very best clinical care can be obtained only when patients have access to the latest evidence that research medicine has to offer.

    The motivation for the current edition is to provide an updated synthesis of the latest research results on a comprehensive range of diseases and conditions that affect women. We include several new areas that have gained attention as important health issues. A fully comprehensive book in one volume is not possible due to space and time constraints, so, together with the section editors, we chose the content not only from those conditions uniquely or predominantly affecting women, but also from those that are understudied and for which research has advanced our understanding in the last decade. In this edition we have placed an emphasis on the older woman, and included topics on changing roles in the family and society that arise later in women’s lives and influence health.

    In preparing this edition we noticed a shift in the authors’ research paradigms. At the time of the first edition, contributors in fields other than reproductive health and other traditionally female-focused specialties had to consciously reflect on how to present gender-related differences in their research. In the last decade, gender awareness has become more reflexive as health researchers and clinicians recognize the importance of understanding biological and gender differences for all diseases. The continued development of a gendered-perspective — for the improvement of the health of women and men — has been the goal of all of us who have contributed to this book.

    As this edition developed, we relied on both contributors to the first edition and also colleagues who joined us for the first time. We are indebted to the section editors, Drs. Lisa Chasan-Taber, Patricia Hartge, Susan Johnson, Suzanne G. Leveille, JoAnn E. Manson, J. Michael Oakes, Rosalind Ramsey-Goldman, Anne M. Rompalo, Karen B. Schmaling, Mary V. Seeman and Jeanne Mager Stellman, who were essential to the project, helping us shape the content, identify areas of research, select contributors, and review the submitted chapters. We are particularly grateful to all of the chapter authors for their commitment to scholarship, and their flexibility and grace in honoring the inevitable deadlines. At Elsevier, we thank our editors, Mara Conner and Megan Wickline.

    We are grateful for the good fortune that brought us together and the humor that forged us into a dynamic editorial collaboration. We also appreciate that, throughout our years of training and research and clinical careers, primarily at Harvard School of Public Health and Harvard Medical School, we have had the privilege of mentorship from and collaboration with many friends and colleagues, including Brian MacMahon, Richard Monson, Dimitrios Trichopoulos, Walter Willett, Robert Hoover, Richard Reindollar, Frank Speizer, Meir Stampfer, Scott Weiss, Julie Buring, Patricia Hartge, Shelia Zahm, Elisabeth Zemp-Stutz, Terry Hartman, Maureen Hatch, and Sue Hankinson.

    Lastly, we thank our friends, families, and colleagues for their constructive criticism and support. Most of all, we thank the health care professionals who spend their lives improving women’s health and well-being and the investigators whose research informs health care and makes this book possible.

    Marlene B. Goldman

    Rebecca Troisi

    Kathryn M. Rexrode

    Preface to the First Edition

    Women are diverse individuals striving to maintain their health within a complex world of cultural, psychological, social, and biological influences. In this light, the content of this book was designed to address the behavioral and societal, as well as the biological, determinants of the health and well-being of women and girls throughout their lifespan. We have known for many years that diseases may not affect women in the same way as they affect men, and that knowledge gained from studying men is not necessarily applicable to understanding disease occurrence, diagnosis, or treatment in women; yet no comprehensive reference text has explicitly taken this into account. Our intent is that the information presented here will improve the quality of thinking about women’s health and in so doing will improve the quality of women’s lives.

    The evolution of women’s health as a discipline is reflected in the breadth and depth of the chapters collected here. We have defined women’s health in broad terms and have chosen not to limit the scope of the book to those conditions uniquely or predominantly affecting women, but to recognize that an understanding of the roles of sex and gender is integral to all aspects of excellent health care and medical research. The preparation of this book required a shift in focus for many of the contributors — from thinking of their discipline as gender-neutral to realizing the importance of examining gender-related differences. Frequently, a potential contributor in an area not historically considered women’s health would say I’ve never considered my research in that way. In fact, we usually control for gender to remove its confounding effects. Then after the chapter was done, these contributors would thank us for asking them to address their research in a new and productive way. The development of a gendered-perspective — for the improvement of the health of women and men — has been the goal of all of us who have brought this book into existence. Creating gender awareness parallels the evolution of the definition of women’s health from concerns about reproduction and traditionally female ailments to encompass the broader vision represented here. Concern for women’s health is not about sexism; it is about unnecessary pain, stress, and mutilation due to lack of prevention strategies and delayed diagnosis and treatment because research on the ways diseases affect women has not been done or disseminated.

    For examples of how pervasive traditional concepts of male-focused medicine can be this late in the 20th century, we need only look at instances where knowledge gained from only one sex (usually male) is thought to be sufficient for application to both. We are reminded of the famous, but unfortunate, marathoner who was suspended after failing a drug test — a test of testosterone hormone levels that was developed for use in male athletes and never validated in women. Her misfortune was that she was a woman. Another example is the initial case definitions for AIDS-related complex and AIDS that were based on signs and symptoms in men. Failure to construct case definitions that include disease characteristics present in women that may not occur in men has put women at a disadvantage in obtaining quality health care. It took 10 years and the realization that some women were presenting with cervical cancer, pelvic inflammatory disease, or candidiasis rather than Kaposi’s sarcoma or pneumocystis pneumonia for the case definition to be changed and for many women to be correctly diagnosed, recognized, and counted in the AIDS epidemic. It is incumbent upon us to challenge those who cling to traditional models by demanding that new drugs be tested in diverse populations that include both sexes, that research studies and clinical trials include women and men, that screening tests be validated in the populations in which they are to be implemented, and that diagnostic and treatment procedures be applied without bias by gender.

    While the rationale for this volume was a recognition that a textbook that provided the medical and scientific community with a synthesis of the latest research results on a comprehensive range of diseases and conditions that affect women was needed, we also intend that the extensive material presented here will assist consumers of health care. It is our conviction that the very best clinical care can be obtained only when patients have access to the cutting-edge knowledge that research medicine has to offer.

    As the book evolved from concept to reality, many individuals provided guidance, professional assistance, and encouragement. We acknowledge several of them here. The idea for this volume developed from conversations with Dr. Dimitrios Trichopoulos, to whom we owe our gratitude for his foresight. Dr. Jennifer Kelsey generously shared her publishing experience and helped us frame our initial proposal. The section editors, Drs. Trudy S. Berkowitz, Louise A. Brinton, Evelyn J. Bromet, Janet R. Daling, Jack M. Guralnik, Suzanne G. Haynes, Roberta B. Ness, Nancy S. Padian, Rosalind Ramsey-Goldman, Karen B. Schmaling, Ellen K. Silbergeld, Glorian Sorensen, Zena A. Stein, and Shelia Hoar Zahm, were essential to the development of the book’s content and mission, assisted in the selection of contributors, and reviewed the submitted chapters. We particularly acknowledge the chapter authors for their commitment to scholarship, flexibility in accommodating multiple revisions, and grace in honoring the deadlines that the timely production of a book of this size necessitated. We are most appreciative of the efforts of one of our colleagues, a contributor to the Reproductive Health Section, Dr. Joseph Mortola, who made a remarkable effort to complete his chapter shortly before his untimely death.

    At Academic Press, Charlotte Brabants, then Acquisitions Editor, was the catalyst for the book. Without Charlotte’s repeated encouragement during the book’s early development, it is unlikely that it would have reached fruition. Tari Paschall expertly saw the assembly of the manuscript through from beginning to end.

    Hazel Emery, Rachelle Ferrari, Destiny Irons, Alvara McBean, and Stacey Missmer cheerfully and efficiently managed the hundreds of clerical and research tasks that kept us on schedule.

    We thank our friends and colleagues Drs. Trudy Berkowitz, Neta Crawford, Shelia Zahm, and Li Zemp for their constructive criticism and support.

    While we have attempted to be comprehensive within time and space constraints, we are aware of health conditions that had to be omitted. We hope that we will be able to include them in future editions. If the information you seek is not here, please let us know.

    Marlene B. Goldman

    Maureen C. Hatch

    List of Contributors

    Numbers in brackets denote the chapters to which the authors contributed.

    Mary E. Abusief, (17), Fertility Physicians of Northern California, Palo Alto, CA, USA

    Dolores Acevedo-Garcia, PhD, MPA-URP, (49), Brandeis University, Institute for Children, Youth and Family Policy, Waltham, MA, USA

    Christine Albert, MD, MPH, (68), Center for Arrhythmia Prevention, Division of Preventive Medicine and Cardiovascular Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA

    D. Lee Alekel, (5), Division of Extramural Research, National Center for Complementary and Alternative Medicine (NCCAM), National Institutes of Health, Bethesda, MD, USA

    Laia Alemany, PhD, (77), Unit of Infections and Cancer, Cancer Epidemiology Research Programme, IDIBELL, CIBERESP, Catalan Institute of Oncology, Spain

    Kelli D. Allen, PhD, (96), Department of Medicine, Division of Internal General Medicine, Duke University Medical Center; and Health Services Research and Development Service, Durham VA Medical Center, Durham, NC, USA

    Lauren M. Anderson, BA, MPH, (37, 38), Department of Health Policy and Management, Mailman School of Public Health, Columbia University, New York, NY, USA

    Benjamin J. Apelberg, PhD, MHS, (46), Center for Tobacco Products, Food and Drug Administration, Rockville, MD, USA

    Hani K. Atrash, MD, MPH, (16), National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA

    Donna Day Baird, PhD, (14), Epidemiology Branch, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, USA

    Noel Bairey C. Merz, MD, FACC, FAHA, (64), Women’s Guild Endowed Chair in Women’s Health Director, Barbra Streisand Women’s Heart Center Director, Preventive Cardiac Center Professor of Medicine Cedars-Sinai Medical Center, Los Angeles, CA, USA

    Carol M. Baldwin, PhD, RN, AHN-BC, FAAN, (94), College of Nursing and Health Innovation; Southwest Borderlands Scholar; Center for World Health Promotion and Disease Prevention; Southwest Interdisciplinary Research Center of Excellence for Health Disparities Research and Training and the North American Center for Transborder Studies, Arizona State University, Phoenix, AZ, USA

    Robert L. Barbieri, MD, (17), Department of Obstetrics, Gynecology, and Reproductive Biology; Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA

    Shirley R. Baron, PhD, (23), Department of Psychiatry and Behavioral Sciences, Northwestern University’s Feinberg School of Medicine; Dept. of Obstetrics and Gynecology, The University of Chicago, Chicago, IL, USA

    Shari S. Bassuk, Sc.D, (Section 8 Introduction and Ch 60), Division of Preventive Medicine, Brigham and Women’s Hospital, Boston, MA, USA

    Lisa M. Bates, (44), Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA

    Jeannette M. Beasley, PhD, MPH, RD, (62), Albert Einstein College of Medicine, Department of Epidemiology and Population Health, Bronx, NY, USA

    Iris R. Bell, MD, PhD, (94), Departments of Family and Community Medicine, College of Medicine; and College of Nursing, The University of Arizona, Tucson, AZ, USA

    C.S. Bergeman, PhD, (102), Department of Psychology, University of Notre Dame, Notre Dame, IN, USA

    Lisa F. Berkman, (44), Harvard Center for Population and Development Studies, Harvard University, Cambridge, MA, USA

    Jonine L. Bernstein, PhD, (73), Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

    Leslie Bernstein, PhD, (72), Division of Cancer Etiology, Department of Population Sciences, Beckman Research Institute, City of Hope, Duarte, CA, USA

    Elizabeth R. Bertone-Johnson, ScD, SM, (13), Division of Biostatistics and Epidemiology, Department of Public Health, University of Massachusetts, Amherst, MA, USA

    Mieke Beth Thomeer, University of Texas at Austin, Austin, TX, USA

    Toni L. Bisconti, BA, MA, PhD (all in psychology), (102), Department of Psychology, University of Akron, Akron, OH, USA

    Janet Blair, PhD, MPH, (33), Division of HIV/AIDS Prevention, US Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA

    Robin P. Bonifas, PhD, MSW, (103), Arizona State University, School of Social Work, Phoenix, AZ, USA

    Xavier F. Bosch, MD, PhD, (77), Unit of Infections and Cancer, Cancer Epidemiology Research Program, Institut Catalá d’Oncologia, IDIBELL, Barcelona, Spain and CIBER Epidemiologia y Salud Publica, Spain

    Judith Bradford, PhD, (6), Center for Population Research in LGBT Health, The Fenway Institute, Boston, MA, USA

    Freddie Bray, BSc. MSc, PhD, (71), Section of Cancer Information, International Agency for Research on Cancer, Lyon, France

    Jennifer D. Brooks, PhD, (73), Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

    Joyce Bromberger, MSW, PhD, (25), Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA, USA

    Joelle M. Brown, PhD, MPH, (23), Department of Psychiatry and Behavioral Sciences, Northwestern University’s Feinberg School of Medicine; Dept. of Obstetrics and Gynecology, The University of Chicago, Chicago, IL, USA

    Laia Bruni, MD, MPH, (77), Unit of Infections and Cancer, Cancer Epidemiology Research Program, Institut Català d’Oncologia, IDIBELL, Barcelona, Spain

    Cynthia M. Bulik, PhD, (87), Department of Psychiatry and Department of Nutrition, University of North Carolina at Chapel Hill, NC, USA

    Ronald T. Burkman, MD, (27), Department of Obstetrics/Gynecology, Baystate Medical Center, Springfield, MA, USA

    Marcy Burstein, PhD, (84), Genetic Epidemiology Research Branch, National Institute of Mental Health, Bethesda, MD, USA

    Cheryl Bushnell, MD, MHS, (66), Department of Neurology and Women’s Health Center of Excellence for Research, Leadership, and Education, Wake Forest School of Medicine, Winston-Salem, NC, USA

    Mary K. Buss, MD, (104), Divisions of Hematology and Oncology, and General Medicine and Primary Care, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA

    Jane A. Cauley, DrPH, (61), Graduate School of Public Health, Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA, USA

    Connie L. Celum, MD, MPH, (30), Global Health, University of Washington, Seattle, WA, USA

    Xinhua Chen, MD, MS, (11), Department of Obstetrics and Gynecology, University of Medicine and Dentistry of New Jersey, Stratford, NJ, USA

    Myriam Chevarie-Davis, MD, MSc, (78), McGill University, Division of Cancer Epidemiology, Montreal, Quebec, Canada

    Stephanie Chiuve, ScD, (68), Center for Arrhythmia Prevention, Division of Preventive Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School and Department of Nutrition, Harvard School of Public Health, Boston, MA, USA

    Patricia O. Chocano-Bedoya, MD, PhD, (13), Division of Biostatistics and Epidemiology, Department of Public Health, University of Massachusetts, Amherst, MA, USA; and Department of Nutrition, Harvard School of Public Health, Boston, MA, USA

    Harjinder Chowdhary, MD, (54), The University of Connecticut Health Center and Medical School, CT, USA

    David C. Christiani, MD, MPH, MS, (54), Harvard School of Public Health, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

    Nadia T. Chung, MPH, (72), Division of Cancer Etiology, Department of Population Sciences, Beckman Research Institute, City of Hope, Duarte, CA, USA

    Carolyn M. Clancy, MD, (3), Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services, Rockville, MD, USA

    Cari Jo Clark, ScD, MPH, (48), Program in Health Disparities Research, Department of Medicine, Medical School, University of Minnesota, MN, USA

    David Conen, MD, MPH, (68), Department of Medicine, University Hospital, Basel, Switzerland

    K.H. Costenbader, MD, MPH, (53), Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, Boston, MA, USA

    Amy Devlin, MD, (53), Division of Rheumatology, Beth Israel Deaconess Medical Center, Boston, MA, USA

    Mireia Diaz, BSc, (77), Unit of Infections and Cancer, Cancer Epidemiology Research Program, Institut Català d’Oncologia, IDIBELL, Barcelona, Spain

    Jeroen Douwes, PhD, (55), Center for Public Health Research, Massey University, Wellington, New Zealand

    Mark Drangsholt, DDS, MSD, PhD, (93), Departments of Oral Medicine and Oral Health Sciences, University of Washington, Seattle, WA, USA

    Ira Driscoll, PhD, (101), Psychology Department, University of Wisconsin-Milwaukee, Milwaukee, WI, USA

    Catherine E. DuBeau, MD, (97), Family and Community Health, and Obstetrics and Gynecology, University of Massachusetts Medical School, Worcester, MA, USA

    Emmeline Edwards, PhD, (5), Division of Extramural Research, National Center for Complementary and Alternative Medicine (NCCAM), National Institutes of Health, Bethesda, MD, USA

    Vera Ehrenstein, MPH, DSc, (7), Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark

    Agustín Escalante, MD, (51), Division of Rheumatology, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA

    Mark A. Espeland, PhD, (101), Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA

    Kathryn C. Fitzgerald, MSc, (67), Division of Preventive Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA

    Betsy Foxman, PhD, (36), University of Michigan, School of Public Health, Ann Arbor, MI, USA

    Eduardo Franco, DrPH, FRSC, FCAHS, (78), DMcGill University, Division of Cancer Epidemiology, Montreal, Quebec, Canada

    William D. Fraser, MD, MSc, FRCS, Dip MFM, (22), University of Montreal, Montreal, QC, Canada

    Karen I. Fredriksen-Goldsen, PhD, (103), University of Washington, School of Social Work, Seattle, WA, USA

    Ellen E. Freeman, PhD, (99), Department of Ophthalmology, Université de Montréal, Montreal, Quebec, Canada

    Melissa C. Friesen, PhD, (42), Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA

    Anne M. Gadermann, PhD, (83), Centre for Health Evaluation and Outcome Sciences, St. Paul’s Hospital, University of British Columbia, Vancouver, BC, Canada

    Mia M. Gaudet, MSPH, PhD, (73), American Cancer Society, Epidemiology Research Program, Atlanta, GA, USA

    Emmy Gavrilidis, BApp Sci, (86), The Monash Alfred Psychiatry Research Center, Central Clinical School, Faculty of Medicine, Monash University, Melbourne, Australia

    Charlotte A Gaydos, MS, MPH, DrPH, (29), Division of Infectious Disease Johns Hopkins School of Medicine, Baltimore, MD, USA

    Kimberly Geronimo, (49), Brandeis University, Institute for Children, Youth and Family Policy, Waltham, MA, USA

    Arline T. Geronimus, ScD, AB, (2), Department of Health Behavior and Health Education, School of Public Health, and Center for Population Studies, Institute for Social Research, University of Michigan, Ann Arbor, MI, USA

    Robin Mary Gillespie, PhD, MPH, (41), RM Gillespie Consulting, New York, NY, USA

    Edward Giovannucci, MD, ScD, (80), Channing Laboratory, Department of Medicine, Harvard Medical School and Brigham and Women’s Hospital, and Department of Nutrition, Harvard School of Public Health, Boston, MA, USA

    Karen Glanz, PhD, MPH, (82), Perelman School of Medicine and School of Nursing, University of Pennsylvania, Philadelphia, PA, USA

    Robert J. Glynn, ScD, PhD, (67), Division of Preventive Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA

    Ellen Gold, MA, PhD, (25), Department of Public Health Sciences, University of California at Davis, Davis, CA, USA

    Shari Goldfarb, MD, (23), Department of Medicine and Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center; Department of Medicine, Weill Cornell Medical College, New York, NY, USA, Breast Cancer Medicine Service and Health Outcomes Research Group at Memorial Sloan-Kettering Cancer Center, Instructor of Medicine at Weill Cornell Medical College, New York, NY, USA

    Marlene B. Goldman, MS, ScD, ( 1, 17), Department of Obstetrics and Gynecology, Dartmouth-Hitchcock Medical Center and Dartmouth Medical School, Lebanon, and Dartmouth Medical School, Hanover, NH, USA

    Emily W. Gower, PhD, (99), Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA

    David A. Grainger, MD, MPH, (20), Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Wichita, KS, USA

    Adèle C. Green, MBBS, PhD, MSc, (81), Queensland Institute of Medical Research, Brisbane, Queensland, Australia; and School of Translational Medicine, University of Manchester, United Kingdom

    Catherine L. Haggerty, PhD, MPH, (35), Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA, USA

    Rebecca Hardy, PhD, (9), Medical Research Council Unit for Lifelong Health and Aging, Division of Population Health, University College London, UK

    Bernard L. Harlow, PhD, (24), Division of Epidemiology & Community Health, University of Minnesota School of Public Health, Minneapolis, MN, USA

    Siobán D. Harlow, PhD, (12, 25), Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA

    Patricia Hartge, ScD, (Section 10), Division of Cancer Epidemiology and Genetics National Cancer Institute, National Institutes of Health, Department of Health and Human Services, USA

    Christine Haskin, MS, DDS, PhD, (100), Department of Clinical Sciences, School of Dental Medicine, University of Nevada Las Vegas, Las Vegas, NV, USA

    Robin Herbert, MD, (41), Department of Preventive Medicine, Mount Sinai School of Medicine, New York, NY, USA

    Victoria L. Holt, PhD, (18), Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA, USA

    Robert N. Hoover, MD, ScD, (Epilogue), Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA

    Maria K. Houtchens, MD, MMSci, (52), Brigham and Women’s Hospital, Harvard Medical School Center for Neurologic Diseases, Multiple Sclerosis Unit, Boston, MA, USA

    Corinne G. Husten, MD, PhD, (46), Center for Tobacco Products, Food and Drug Administration, Rockville, MD, USA

    Loris Y. Hwang, MD, (34), Division of Adolescent and Young Adult Medicine, Department of Pediatrics, UCSF Benioff Children’s Hospital, University of California, San Francisco, CA, USA

    Noreen A. Hynes, MD, MPH, (28), Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Peter James, ScD, (50), Department of Epidemiology, Department of Environmental Health, Harvard School of Public Health, Boston, MA, USA

    Elizabeth Jewell, MD, MHSc, (76), Memorial Sloan-Kettering Cancer Center, New York, NY, USA

    Susan K. Johnson, PhD, (Section 12 Introduction and Ch 89), Department of Psychology, University of North Carolina – Charlotte, Charlotte, NC, USA

    Pamela Joshi, PhD, MPP, (49), Brandeis University, Institute for Children, Youth and Family Policy, Waltham, MA, USA

    Corinne E. Joshu, PhD, MPH, (80), Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

    Mary L. Kamb, MD, MPH, (33), Division of STD Prevention, CDC, Atlanta, GA, USA

    Carrie Karvonen-Gutierrez, MPH, PhD, (25), Department of Epidemiology, University of Michigan, Ann Arbor, MI, USA

    Ronald C. Kessler, PhD, (83), Department of Health Care Policy, Harvard Medical School, Boston, MA, USA

    Maheruh Khandker, MHS, (24), Division of Epidemiology & Community Health, University of Minnesota School of Public Health, Minneapolis, MN, USA

    Samia J. Khoury, MD, (52), Brigham and Women’s Hospital, Harvard Medical School Center for Neurologic Diseases, Multiple Sclerosis Unit, Boston, MA, USA

    Autumn M. Klein, MD, PhD, (91), Division of Women’s Neurology, Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA

    Natasha A. Koloski, PhD, (92), Faculty of Health, University of Newcastle, Callaghan, New South Wales, Australia

    Diana Kuh, PhD, FFPH, (9), Medical Research Council Unit for Lifelong Health and Aging, Division of Population Health, University College London, UK

    Jayashri Kulkarni, MBBS, MPM, PhD, FRANZCP, (86), The Monash Alfred Psychiatry Research Centre, Central Clinical School, Faculty of Medicine, Monash University, Melbourne, Australia

    Lewis H. Kuller, (56), University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA

    James V. Lacey Jr., PhD, (72), Division of Cancer Etiology, Department of Population Sciences, Beckman Research Institute, City of Hope, Duarte, CA, USA

    Andrea Z. LaCroix, PhD, (62), Fred Hutchinson Cancer Research Center, Public Health Sciences Division, Seattle, WA, USA

    Francine Laden, ScD, (50), Department of Epidemiology, Department of Environmental Health, Harvard School of Public Health, Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA

    Timothy L. Lash, (7), Department of Clinical Epidemiology, Aarhus University Hospital, Denmark and Department of Epidemiology and Prevention Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA

    Shannon K. Laughlin-Tommaso, MD, MPH, (19), Department of Obstetrics and Gynecology and Surgery, Mayo Clinic and Mayo Medical School, Rochester, MN, USA

    Cathy C. Lee, MD, (57), Department of Medicine, David Geffen School of Medicine at UCLA; and VA Greater Los Angeles Geriatrics, Research, Education and Clinical Center, Los Angeles, CA, USA

    Ji Youn Lee, BA, (58), Boston University School of Medicine, Boston, MA, USA

    Stephanie L. Lee, MD, PhD, (58), Section of Endocrinology, Diabetes and Nutrition, Department of Medicine, Boston University School of Medicine, Boston Medical Center, Boston, MA, USA

    Linda LeResche, ScD, (93), Departments of Oral Medicine and Oral Health Sciences, University of Washington, Seattle, WA, USA

    Suzanne G. Leveille, PhD, RN, (Section 13 Introduction and Ch 95), Department of Nursing, College of Nursing and Health Sciences, University of Massachusetts, Boston; Division of General Medicine and Primary Care, Department of Medicine, Beth Israel Deaconess Medical Center, Department of Medicine, Harvard Medical School, Boston, MA, USA

    Jannet F. Lewis, MD, FACC, FAHA, (64), Professor of Medicine, Division of Cardiology Director, Noninvasive Cardiology, George Washington University Medical Center,Washington, DC

    Frank R. Lin, MD, PhD, (98), Department of Otolaryngology – Head and Neck Surgery and Epidemiology, Johns Hopkins University; and Center on Aging and Health, Johns Hopkins Medical Institutions, Baltimore, MD, USA

    Stacy Tessler Lindau, (23), Department of Obstetrics and Gynecology Program in Integrative Sexual Medicine for Women and Girls with Cancer, Department of Medicine-Geriatrics, and The Comprehensive Cancer Center, The University of Chicago, Chicago, IL, USA

    Marja-Liisa Lindbohm, PhD, (40), Center of Expertise for Health and Work Ability, Finnish Institute of Occupational Health, Helsinki, Finland

    Simin Liu, MD, (57), Department of Medicine, David Geffen School of Medicine at UCLA; and VA Greater Los Angeles Geriatrics, Research, Education and Clinical Center, Los Angeles, CA, USA

    Donald M. Lloyd-Jones, MD, ScM, FACC, FAHA, (69), Department of Preventive Medicine and Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

    Joannie Lortet-Tieulent, MSc, (71), Section of Cancer Information, International Agency for Research on Cancer, Lyon, France

    Andrea Lucas, (38), Department of Health Policy & Management, Mailman School of Public Health, Columbia University, New York, NY, USA

    Rachel H. Mackey, PhD, MPH, FAHA, (56), Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA

    Jeanne Mager Stellman, PhD, (37, 38), Department of Health Policy & Management, Mailman School of Public Health, Columbia University, New York, NY, USA

    Ann Marie Malarcher, PhD, (46), Office on Smoking and Health, Centers for Disease Control and Prevention, Atlanta, GA, USA

    JoAnn E. Manson, MD, DrPH, (Section 8 Introduction and Ch 60), Division of Preventive Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

    Lynette J. Margesson, MD, (24), Departments of Obstetrics, Gynecology and Surgery (Dermatology), Dartmouth Medical School, Hanover, NH, USA

    M. Maria Glymour, SD, (44), Department of Society, Human Development and Health, Harvard School of Public Health, Boston, MA, USA

    Jeanne M. Marrazzo, MD, MPH, (30), Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA

    Karen Matthews, PhD, (25), Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA

    Suzanne E. Mazzeo, PhD, (87), Department of Psychology, Virginia Commonwealth University, Richmond, VA, USA

    Ellen P. McCarthy, PhD, MPH, (104), Division of General Medicine and Primary Care, Department of Medicine, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, MA, USA

    Valerie McCormack, PhD, MSc, (71), Section of Environment and Radiation, International Agency for Research on Cancer, Lyon, France

    Thomas F. McElrath, MD, PhD, (21), Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

    Romy-Leigh McMaster, MSc, (22), University of Montreal, Montreal, QC, Canada

    Kathleen M. McTigue, MD, MS, MPH, (56), University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA

    Kathleen Ries Merikangas, PhD, (84), Genetic Epidemiology Research Branch, National Institute of Mental Health, Bethesda, MD, USA

    C. Noel Bairey Merz, MD, DrPH, (53), Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

    Karen Messing, PhD, (39), Department of Biological Sciences and CINBIOSE Research Centre, Université du Québec à Montréal, Montréal, Québec, Canada

    Anthony B. Miller, MD, FRCP, FACE, (74), Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada

    Daniel R. Mishell Jr., MD, (15), Keck School of Medicine, University of Southern California, Los Angeles, CA, USA

    Stacey A. Missmer, ScM, ScD, (17), Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA

    Connie Mobley, MS, DDS, PhD, (100), Department of Clinical Sciences, School of Dental Medicine, University of Nevada Las Vegas, Las Vegas, NV, USA

    Anna-Barbara Moscicki, MD, (34), Division of Adolescent and Young Adult Medicine, Department of Pediatrics, UCSF Benioff Children’s Hospital, University of California, San Francisco, CA, USA

    Tyler Muffly, MD, (26), Cleveland Clinic, Department of Obstetrics and Gynecology, Cleveland, OH, USA

    Christina A. Muzny, MD, (31), Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA

    Amanda E. Nelson, MD, MSCR, (96), Department of Medicine, Division of Rheumatology, Allergy, and Immunology, University of North Carolina at Chapel Hill; and Thurston Arthritis Research Center, Chapel Hill, NC, USA

    Enjoying the preview?
    Page 1 of 1